,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2012-05-03 06:50:00,Clorox Corporation ( CLX ) posted third-quarter 2012 earnings per share of $1.05 compared with $1.03 earned in the prior-year quarter.,0.6029559969902039,0.37095320224761963,0.026090746745467186,positive,0.23200279474258423
1,2012-05-03 06:50:00,"However, considering foreign exchange impact quarterly earnings came in at $1.04 per share.",0.11030098050832748,0.28231358528137207,0.6073853969573975,neutral,-0.172012597322464
2,2012-05-03 06:50:00,The earnings in the quarter were also above the Zacks Consensus Estimate of $1.03.,0.8875217437744141,0.07108032703399658,0.04139791801571846,positive,0.8164414167404175
3,2012-05-03 06:50:00,"On a reported basis, including one-time items, the company reported earnings per share of $1.01 versus $1.09 reported in the year-ago quarter.",0.48159587383270264,0.49101343750953674,0.027390694245696068,negative,-0.009417563676834106
4,2012-05-03 06:50:00,"During the quarter, the company's earnings benefited from the ongoing cost-saving initiatives and price increases, while higher raw material, manufacturing and logistics costs, poor product and country mix, and spends on Information Technology (IT) systems and research & development (R&D) facilities were minor deterrents.",0.6276716589927673,0.3097926378250122,0.06253571063280106,positive,0.3178790211677551
5,2012-05-03 06:50:00,"Clorox's net sales during the quarter were up 7% year over year to $1,401 million from $1,304 million in the year-ago quarter, driven by volume growth, contributions from new businesses acquired earlier in the year as well as strength across all of the company's reportable segments.",0.9596855044364929,0.020806530490517616,0.019508013501763344,positive,0.9388789534568787
6,2012-05-03 06:50:00,Revenue also benefited from price increases across the board.,0.9475563168525696,0.017641056329011917,0.03480268269777298,positive,0.9299152493476868
7,2012-05-03 06:50:00,"Total revenue also surpassed the Zacks Consensus Estimate of $1,352 million.",0.9463692903518677,0.019247865304350853,0.03438277170062065,positive,0.9271214008331299
8,2012-05-03 06:50:00,Total volumes grew 4% year over year mainly due to product innovation across the portfolio and strong retailer merchandising on several brands.,0.9590386152267456,0.017595944926142693,0.02336542308330536,positive,0.9414426684379578
9,2012-05-03 06:50:00,"Sales in the Cleaning segment grew 10% primarily due to 7% volume growth, gains in the Away From Home and Home Care business, price increases in the Laundry business, offset by lower shipments in the Laundry business.",0.9424747824668884,0.027353934943675995,0.030171243473887444,positive,0.9151208400726318
10,2012-05-03 06:50:00,Household segment sales increased 6% primarily due to 2% growth in volume and increased pricing.,0.9552462697029114,0.017267515882849693,0.027486184611916542,positive,0.9379787445068359
11,2012-05-03 06:50:00,Higher volumes resulted from growth in shipments in all three business segments.,0.9473609924316406,0.01642552949488163,0.036213453859090805,positive,0.9309354424476624
12,2012-05-03 06:50:00,"Clorox's Lifestyle segment recorded a 10% sales jump in the quarter compared with the base period a year ago, on the back of a 4% volume growth and increased pricing.",0.9577001929283142,0.025105681270360947,0.017194058746099472,positive,0.9325945377349854
13,2012-05-03 06:50:00,The volume growth was primarily driven by higher shipments in all of the segment's businesses.,0.932579755783081,0.015367078594863415,0.05205310508608818,positive,0.9172126650810242
14,2012-05-03 06:50:00,"In the International business segment, Clorox's sales rose 4%, benefiting from price increases and 1% volume growth, partially offset by unfavorable foreign currency fluctuation and increase in trade-promotion expenditure.",0.9606497883796692,0.022077323868870735,0.017272913828492165,positive,0.9385724663734436
15,2012-05-03 06:50:00,"Volumes in the quarter benefited from increased shipments of home care products in the company's largest international region, Latin America, offset by lower shipments in the non-strategic export business, and a double-digit volume decline in Venezuela.",0.5254573225975037,0.45064371824264526,0.02389901503920555,positive,0.0748136043548584
16,2012-05-03 06:50:00,Clorox's gross margin decreased 180 basis points (bps) to 42.3% from 44.1% in the year-ago quarter.,0.02283167839050293,0.9706652164459229,0.0065030911937355995,negative,-0.9478335380554199
17,2012-05-03 06:50:00,"Increased commodity, manufacturing and logistics costs, unfavorable product and country mix more than offset benefits from price increases and prudent cost savings, leading to gross margin contraction.",0.021454857662320137,0.9687179327011108,0.009827238507568836,negative,-0.9472630620002747
18,2012-05-03 06:50:00,"At quarter-end, Clorox had cash and cash equivalents of $303 million and long-term debt of $1,570 million.",0.01567888632416725,0.015363704413175583,0.9689573645591736,neutral,0.0003151819109916687
19,2012-05-03 06:50:00,"For the nine months ended March 31, 2012, the company generated $333 million cash from operations, a $54 million decline from the year-ago period.",0.03582156077027321,0.9553905725479126,0.008787889964878559,negative,-0.9195690155029297
20,2012-05-03 06:50:00,"Looking ahead, the company adjusted its annual sales growth guidance for fiscal 2012 to 4%, against the company's previous guidance range of 2% - 4%.",0.9076826572418213,0.031277064234018326,0.061040278524160385,positive,0.8764055967330933
21,2012-05-03 06:50:00,"The revised guidance reflected betterment in the U.S. categories as well as robust results on the back of innovation, price increase and merchandising initiatives.",0.9553217887878418,0.017296208068728447,0.027381939813494682,positive,0.9380255937576294
22,2012-05-03 06:50:00,"F

urther, though the company expects strong sales growth in the fourth quarter, it is not as strong as the third quarter.",0.9169420003890991,0.027201736345887184,0.05585632845759392,positive,0.8897402882575989
23,2012-05-03 06:50:00,This compares to the company's record sales growth of 4% in the fourth quarter of 2011.,0.8513821363449097,0.08656411617994308,0.06205371767282486,positive,0.764818012714386
24,2012-05-03 06:50:00,Clorox continues to anticipate annual earnings of $4.00 to $4.10 per share in fiscal 2012.,0.700962483882904,0.015544652007520199,0.28349289298057556,positive,0.6854178309440613
25,2012-05-03 06:50:00,"However, gross margin guidance for 2012 was revised to reflect a decline of 125 - 150 basis points compared to the previous guidance of 50 - 75 basis points contraction, due to the continued adverse impact of product and country mix.",0.02697715163230896,0.9620252251625061,0.010997569188475609,negative,-0.9350481033325195
26,2012-05-03 06:50:00,"For fiscal 2012, Clorox expects to generate free cash flow of about 9% of sales.",0.4062170684337616,0.012953422963619232,0.5808295011520386,neutral,0.39326363801956177
27,2012-05-03 06:50:00,"Additionally, the company also rolled out its fiscal 2013 guidance, projecting sales growth in the range of 2% - 4%.",0.8988375067710876,0.013905392028391361,0.08725707232952118,positive,0.8849321007728577
28,2012-05-03 06:50:00,"Operating income margin for fiscal 2013 is expected to be flat, on the back of a moderate expansion in gross margin offset by increased administrative expenses.",0.023748323321342468,0.95473313331604,0.021518513560295105,negative,-0.9309847950935364
29,2012-05-03 06:50:00,The company expects cost containment efforts and price hikes to offset increasing commodities and other manufacturing costs.,0.9090680480003357,0.019361447542905807,0.0715705081820488,positive,0.8897066116333008
30,2012-05-03 06:50:00,"Further, the company guides expenditure toward systems and facilities development and other restructuring initiatives to be in the range of $50 - $55 million in fiscal 2012.",0.36539173126220703,0.011940623633563519,0.6226676106452942,neutral,0.35345110297203064
31,2012-05-03 06:50:00,The company anticipates fiscal 2013 earnings per share to be in the range of $4.20 - $4.35.,0.07670088112354279,0.012010456994175911,0.9112886786460876,neutral,0.06469042599201202
32,2012-05-03 06:50:00,"The Zacks Consensus Estimate for fiscal 2012 and 2013 stands at $4.07 per share and 4.30 per share, respectively, which lie within the company's guidance range for both periods.",0.062049154192209244,0.016050152480602264,0.921900749206543,neutral,0.04599900171160698
33,2012-05-03 06:50:00,"Clorox is making intensive capital investments in information technology systems and capabilities, particularly in the international market and R&D facilities to boost productivity while providing platforms for growth, product innovation and cost savings.",0.856605052947998,0.0106852687895298,0.13270968198776245,positive,0.8459197878837585
34,2012-05-03 06:50:00,The company believes that these initiatives will begin delivering benefits later in fiscal 2014 and beyond.,0.797470211982727,0.011862308718264103,0.1906675398349762,positive,0.7856078743934631
35,2012-05-03 06:50:00,"Clorox faces intense competition from other well-established consumer product companies, both in the U.S. and international markets.",0.5733254551887512,0.05480704456567764,0.3718675374984741,positive,0.5185183882713318
36,2012-05-03 06:50:00,"Most of the company's products compete with other widely advertised brands within each product category and private label brands and generic non-branded products of grocery chains and wholesale cooperatives in certain categories, which typically are sold at lower prices.",0.04481123015284538,0.02004513144493103,0.9351436495780945,neutral,0.024766098707914352
37,2012-05-03 06:50:00,The main competitors of Clorox are Colgate-Palmolive Company ( CL ) and Procter and Gamble Company ( PG ).,0.013407453894615173,0.011033873073756695,0.9755586981773376,neutral,0.0023735808208584785
38,2012-05-03 06:50:00,"Currently, Clorox has a Zacks #4 Rank, implying a short-term Sell rating.",0.28168582916259766,0.019078826531767845,0.6992353796958923,neutral,0.26260700821876526
39,2012-05-03 06:50:00,"However, we have a long-term Neutral recommendation on the stock.",0.02976071834564209,0.04136376827955246,0.9288755059242249,neutral,-0.01160304993391037
40,2012-05-03 06:50:00,To read this article on Zacks.com click here.,0.01796119473874569,0.0192450862377882,0.9627937078475952,neutral,-0.001283891499042511
41,2012-05-03 06:50:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
